32.85
전일 마감가:
$31.76
열려 있는:
$31.68
하루 거래량:
805.83K
Relative Volume:
0.95
시가총액:
$1.39B
수익:
$656.32M
순이익/손실:
$-164.17M
주가수익비율:
-11.03
EPS:
-2.9794
순현금흐름:
$12.90M
1주 성능:
+7.67%
1개월 성능:
+23.36%
6개월 성능:
-34.35%
1년 성능:
-36.25%
Azenta Inc Stock (AZTA) Company Profile
명칭
Azenta Inc
전화
(978) 262-2400
주소
200 SUMMIT DRIVE, BURLINGTON
AZTA을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
AZTA
Azenta Inc
|
32.85 | 1.39B | 656.32M | -164.17M | 12.90M | -2.9794 |
![]()
ISRG
Intuitive Surgical Inc
|
540.60 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
BDX
Becton Dickinson Co
|
177.27 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
89.30 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
255.88 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
WST
West Pharmaceutical Services Inc
|
221.22 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-12-18 | 업그레이드 | Stephens | Equal-Weight → Overweight |
2024-04-04 | 개시 | Jefferies | Hold |
2024-02-01 | 재확인 | B. Riley Securities | Buy |
2023-07-19 | 개시 | Raymond James | Mkt Perform |
2023-05-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
2023-02-09 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
2022-03-31 | 재개 | B. Riley Securities | Buy |
2022-03-21 | 개시 | Evercore ISI | Outperform |
모두보기
Azenta Inc 주식(AZTA)의 최신 뉴스
Azenta Inc (AZTA) Trading 3.24% Higher on Jun 18 - GuruFocus
Shareholders in Azenta (NASDAQ:AZTA) have lost 59%, as stock drops 3.6% this past week - Yahoo Finance
SG Americas Securities LLC Has $1.07 Million Stock Position in Azenta, Inc. (NASDAQ:AZTA) - Defense World
GAMMA Investing LLC Increases Stake in Azenta, Inc. (NASDAQ:AZTA) - Defense World
California State Teachers Retirement System Sells 5,299 Shares of Azenta, Inc. (NASDAQ:AZTA) - Defense World
Azenta, Inc. (NASDAQ:AZTA) Shares Acquired by Deutsche Bank AG - Defense World
Cetera Investment Advisers Sells 539 Shares of Azenta, Inc. (NASDAQ:AZTA) - Defense World
Millennium Management LLC Purchases 17,899 Shares of Azenta, Inc. (NASDAQ:AZTA) - Defense World
Is Now An Opportune Moment To Examine Azenta, Inc. (NASDAQ:AZTA)? - Yahoo
Azenta, Inc. (NASDAQ:AZTA) Position Lessened by Man Group plc - Defense World
Enhance Laboratory Efficiency with Azenta’s CryoPod Carrier - Lab Manager
Ameriprise Financial Inc. Increases Holdings in Azenta, Inc. (NASDAQ:AZTA) - Defense World
Captrust Financial Advisors Acquires 2,026 Shares of Azenta, Inc. (NASDAQ:AZTA) - Defense World
The Manufacturers Life Insurance Company Has $447,000 Holdings in Azenta, Inc. (NASDAQ:AZTA) - Defense World
Azenta Announces Leadership Change with New General Counsel - TipRanks
Azenta Life Sciences and Form Bio Announce Strategic Partnership - GuruFocus
Northern Trust Corp Reduces Stake in Azenta, Inc. (NASDAQ:AZTA) - Defense World
Azenta (AZTA) Partners with Form Bio to Advance AAV Gene Therapy - GuruFocus
Azenta, Form Bio Launch Partnership for AAV Gene Therapy - marketscreener.com
Azenta Life Sciences And Form Bio Announce Strategic Partnership To Advance AAV Gene Therapy Development - marketscreener.com
Azenta, Form Bio announce strategic partnership - TipRanks
Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development - Nasdaq
Azenta, Inc. (NASDAQ:AZTA) Shares Sold by Voya Investment Management LLC - Defense World
Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know - Yahoo Finance
Azenta to Participate in the UBS MedTech, Tools and Genomics Summit 2023 - Seeking Alpha
AZTA Q1 Earnings Call: Revenue Tops Expectations, Margin Progress Amid Macro Headwinds - FinancialContent
Price T Rowe Associates Inc. MD Increases Stock Holdings in Azenta, Inc. (NASDAQ:AZTA) - The AM Reporter
Needham & Company LLC Lowers Azenta (NASDAQ:AZTA) Price Target to $40.00 - Defense World
Balance Sheet Insights: Azenta Inc (AZTA)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX
Azenta targets 3%-5% organic growth and expands automation initiatives for FY2025 - MSN
Azenta, Inc. (NASDAQ:AZTA) Q2 2025 Earnings Call Transcript - Insider Monkey
First Trust Advisors LP Buys New Stake in Azenta, Inc. (NASDAQ:AZTA) - Defense World
Azenta Inc (AZTA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Macroeconomic ... - Yahoo
Azenta (NASDAQ:AZTA) Hits New 1-Year Low Following Weak Earnings - Defense World
Azenta Inc (AZTA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Macroeconomic Challenges - GuruFocus
Azenta, Inc. Reports Solid Q2 2025 Revenue Growth - TipRanks
Azenta, Inc. Reports Strong Q2 2025 Earnings - TipRanks
Azenta (AZTA) Price Target Lowered by Needham to $40 | AZTA Stoc - GuruFocus
Azenta Q2 2025 slides: Revenue growth returns with 400 bps margin expansion By Investing.com - Investing.com South Africa
Azenta (AZTA) Price Target Lowered by Needham to $40 | AZTA Stock News - GuruFocus
Transcript : Azenta, Inc., Q2 2025 Earnings Call, May 07, 2025 - marketscreener.com
Needham Adjusts Price Target on Azenta to $40 From $59, Keeps Buy Rating - marketscreener.com
Earnings call transcript: Azenta’s Q2 2025 results miss EPS forecast, stock rises - Investing.com Australia
Azenta Q2 2025 slides: Revenue growth returns with 400 bps margin expansion - Investing.com India
Azenta Fiscal Q2 Non-GAAP Earnings Fall, Revenue Rises - marketscreener.com
Azenta Surpasses Revenue Expectations in Q1 CY2025News and Statistics - IndexBox
Azenta (NASDAQ:AZTA) Beats Q1 Sales Targets - FinancialContent
Azenta (AZTA) Reports Q2 Earnings with Revenue Decline - GuruFocus
Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025 | AZTA Stock News - GuruFocus
Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025 - Quantisnow
Azenta expands PCR plate range - European Pharmaceutical Manufacturer
Azenta Inc (AZTA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Azenta Inc 주식 (AZTA) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Zhou Ginger | SVP and General Manager, Genom |
Jan 31 '25 |
Buy |
45.88 |
417 |
19,132 |
27,916 |
Pirogova Olga | SVP and CHRO |
Nov 19 '24 |
Sale |
40.07 |
548 |
21,958 |
19,373 |
Hughes Violetta | VP, Chief Accounting Officer |
Nov 19 '24 |
Sale |
40.07 |
163 |
6,531 |
9,920 |
Zhou Ginger | SVP and General Manager, Genom |
Nov 19 '24 |
Sale |
40.07 |
491 |
19,674 |
27,499 |
Wang David Dong | SVP & GM, SMS |
Nov 19 '24 |
Sale |
40.07 |
348 |
13,944 |
24,114 |
Joseph Jason | SVP, General Counsel, Secy. |
Nov 19 '24 |
Sale |
40.07 |
1,139 |
45,640 |
112,564 |
Cueto Herman | EVP, Chief Financial Officer |
Nov 19 '24 |
Sale |
40.07 |
712 |
28,530 |
23,892 |
Marotta John | President and CEO |
Nov 18 '24 |
Buy |
39.48 |
12,717 |
502,066 |
99,612 |
Marotta John | President and CEO |
Nov 19 '24 |
Buy |
40.67 |
1,250 |
50,838 |
100,862 |
Cornog William L | Director |
Nov 18 '24 |
Buy |
39.60 |
12,500 |
495,000 |
14,755 |
자본화:
|
볼륨(24시간):